CONTINUE TO SITE

OR WAIT null SECS

COVID-19 Update Analytics Development Downstream Processing Manufacturing Outsourcing Quality/GMPs Upstream Processing

COVID-19 UpdateAnalyticsDevelopmentDownstream ProcessingManufacturingOutsourcingQuality/GMPsUpstream Processing

View More Analytical Methods BioBusiness Cell Culture/Fermentation Continuous Processing Drug Delivery Fill/Finish Formulation Process Chromatography Process Control/PAT Process Development QA/QC Separation and Purification Single-Use Systems Supply Chain

Analytical MethodsBioBusinessCell Culture/FermentationContinuous ProcessingDrug DeliveryFill/FinishFormulationProcess ChromatographyProcess Control/PATProcess DevelopmentQA/QCSeparation and PurificationSingle-Use SystemsSupply Chain

News

All News Top News Bio/Pharma News Industry News Supplier News Events

All NewsTop NewsBio/Pharma NewsIndustry NewsSupplier NewsEvents

Publications

All Publications BioPharm International

All PublicationsBioPharm International

Resources

Biopharma Insights Sponsored eBooks Sponsored Podcasts Sponsored Videos Whitepapers

Biopharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers

Webcasts

Enews Magazine

EnewsMagazine

About Us
Advertise
Editorial Information
Contact Us
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Spotlight

COVID-19 Update
Analytics
Development
Downstream Processing
Manufacturing
Outsourcing
Quality/GMPs
Upstream Processing

TopicSee All >

Analytical Methods
BioBusiness
Cell Culture/Fermentation
Continuous Processing
Drug Delivery
Fill/Finish
Formulation
Process Chromatography
Process Control/PAT
Process Development
QA/QC
Separation and Purification
Single-Use Systems
Supply Chain

About Us
Advertise
Editorial Information
Contact Us
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Manufacturing

home

The Evolving Aseptic Processing Landscape

Single-use technologies allowed drug manufacturers to adapt to pandemic challenges.

Clean Factory Systems

Help prevent contamination in each of seven facility zones.

Researchers Cite Positive Results in COVID-19 Microneedle Patch Trial

September 24, 2021

Researchers in China report test results for a microneedle patch for COVID-19 vaccine delivery.

Celsion and Poly Pharm to Manufacture Celsion’s DNA-Based Vaccine

September 23, 2021

In an amendment to their existing contract manufacturing agreement, Celsian and Poly Pharm expand GEN-1 program collaboration to add clinical and commercial batches of investigational vaccine.

Real-World Evidence Shows Strong Protection from COVID-19 with J&J Vaccine and Booster

September 23, 2021

New data finds J&J COVID-19 vaccine and booster to provide increased protection against COVID-19.

Lonza to Expand Capabilities at Manufacturing Sites in Switzerland

September 22, 2021

Lonza’s investment in its Stein and Basel facilities in Switzerland aims to expand its overall drug product development and manufacturing services.

Celularity and Oncternal Therapeutics to Research Placental-Derived Cellular Therapies

September 22, 2021

Celularity and Oncternal’s collaboration will focus on therapeutics targeting Orphan Receptor 1, which is linked to aggression and survival in solid tumor cells.

New Sterile Connectors for Small-Bore Tubing Offer an Alternative to Welding

September 16, 2021

CPC’s MicroCNX Series Connectors provide an alternative to tube welding at small tubing sizes.

Repligen and Navigo GmbH Launch Industry-First Protein A Ligand for Purification of pH-Sensitive Antibodies

September 14, 2021

Repligen and Navigo’s novel ligand could be the first to address antibody aggregation in low pH elution buffers.

AGC Bio Boosts Manufacturing Capacity for pDNA and mRNA at Heidelberg Facility

September 14, 2021

AGC Biologics is expanding manufacturing capacity at its Heidelberg, Germany, facility for plasmid DNA and messenger RNA.

Moderna to Develop Combined COVID-19/Flu Vaccine

September 09, 2021

Moderna’s new single-dose vaccine will be a booster for both COVID-19 and the flu.

AstraZeneca and European Commission Reach Settlement Agreement Over COVID-19 Vaccine Supply

September 09, 2021

AstraZeneca and the European Commission have reached an agreement that ends legal proceedings over the execution of the advance purchase agreement for the delivery of Vaxzevria.